pharmaceutical investing EyeGate Completes Enrollment and Receives Milestone Payment for Confirmatory Phase 3 Clinical Study of EGP-437
G1 Therapeutics Reports Fourth Quarter and Full-Year 2017 Financial Results and Recent Operational Highlights
Spartan Metals' Exploration Program Confirms Tungsten Skarn Discoveries at past Producing Mine at Eagle Project, Nevada
Star Copper Extends Copper Creek Drill Hole Beyond Planned Depth After Intersecting Mineralized System
